BCG疫苗接种后1型糖尿病糖代谢相关表观遗传变化及KDM2B作用
一项临床试验的BIOMARKER分析,在13例1型糖尿病和8例对照者中,用Illumina甲基化芯片检测CD4+T淋巴细胞。BCG接种后3年内,大部分异常甲基化位点被纠正,KDM2B和DDIT4基因启动子区从低甲基化转为高甲基化,mRNA改变相应。
要点
- 1型糖尿病与2型糖尿病异常甲基化CpG位点部分重叠但不完全一致。
- BCG接种后3年内多数异常甲基化位点被纠正。
- KDM2B和DDIT4基线低甲基化,BCG后高甲基化且mRNA相应改变。
核心结论
- BCG接种可在体内纠正1型糖尿病中与糖代谢相关的异常甲基化模式。
- KDM2B和DDIT4基因参与BCG驱动的组蛋白再甲基化及mTOR通路调控。
研究设计与样本
- 临床试验中的生物标志物分析,1型糖尿病13例和对照8例,BCG接种后每年随访共3年。
- 甲基化检测用Illumina Methylation EPIC BeadChip,mRNA分析用RNAseq。
主要发现
- 1型糖尿病与2型糖尿病在异常甲基化CpG位点上存在广泛但不完全的重叠。
- BCG接种后3年观察期内,大部分异常甲基化位点被纠正。
- KDM2B和DDIT4的突出CpG位点在基线时相对对照低甲基化,BCG接种后高甲基化纠正缺陷。
- BCG在基因水平的效应由mRNA的相应变化确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A recent epigenome-wide association study of genes associated with type 2 diabetics (T2D), used integrative cross-omics analysis to identify 22 abnormally methylated CpG sites associated with insulin and glucose metabolism. Here, in this epigenetic analysis we preliminarily determine whether the same CpG sites identified in T2D also apply to type 1 diabetes (T1D). We then determine whether BCG vaccination could correct the abnormal methylation patterns, considering that the two diseases share metabolic derangements. METHODS: T1D (n = 13) and control (n = 8) subjects were studied at baseline and then T1D subjects studied yearly for 3 years after receiving BCG vaccinations in a clinical trial. In this biomarker analysis, methylation patterns were evaluated on CD4+ T-lymphocytes from baseline and yearly blood samples using the human Illumina Methylation EPIC Bead Chip. Methylation analysis combined with mRNA analysis using RNAseq. RESULTS: Broad but not complete overlap was observed between T1D and T2D in CpG sites with abnormal methylation. And in the three-year observation period after BCG vaccinations, the majority of the abnormal methylation sites were corrected in vivo. Genes of particular interest were related to oxidative phosphorylation (CPT1A, LETM1, ABCG1), to the histone lysine demethylase gene (KDM2B), and mTOR signaling through the DDIT4 gene. The highlighted CpG sites for both KDM2B and DDIT4 genes were hypomethylated at baseline compared to controls; BCG vaccination corrected the defect by hypermethylation. CONCLUSIONS: Glycolysis is regulated by methylation of genes. This study unexpectedly identified both KDM2B and DDIT4 as genes controlling BCG-driven re-methylation of histones, and the activation of the mTOR pathway for facilitated glucose transport respectively. The BCG effect at the gene level was confirmed by reciprocal mRNA changes. The DDIT4 gene with known inhibitory role of mTOR was re-methylated after BCG, a step likely to allow improved glucose transport. BCGs driven methylation of KDM2B's site should halt augmented histone activity, a step known to allow cytokine activation and increased glycolysis.
引用
- Dias HF, Kühtreiber WM, Nelson KJ, et al. Epigenetic changes related to glucose metabolism in type 1 diabetes after BCG vaccinations: A vital role for KDM2B. Vaccine. 2021. PMID: 33933315. doi:10.1016/j.vaccine.2021.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。